Longitudinal changes in subclinical vascular disease in Ugandan youth with HIV.

Sahera Dirajlal-FargoChenya ZhaoDanielle LabbatoAbdus SattarChristine KarungiChris T LongeneckerRashidah NazzindaNicholas FunderburgCissy KityoVictor MusiimeGrace A McCOMSEY

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)

In healthy Ugandan PHIV, with viral suppression on ART, common carotid IMT did not progress over 2 years. Prolonged and early ART may prevent progression of subclinical vascular disease, while prolonged use of abacavir may increase it.

Keyphrases

antiretroviral therapy
hiv infected
hiv positive
human immunodeficiency virus
physical activity
hepatitis c virus
mental health
hiv testing